Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03749187
Title BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (PNOC017)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of California, San Francisco
Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST